We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03298412
Brief Title: Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

First Submitted : September 12, 2017
First Submitted that Met QC Criteria : September 26, 2017
First Posted : October 2, 2017

Results First Submitted : August 20, 2020
Results First Posted with QC Comments : September 3, 2020
Results First Submitted that Met QC Criteria : September 10, 2020
Results First Posted : September 11, 2020

Last Update Submitted that Met QC Criteria : September 10, 2020
Last Update Posted : September 11, 2020